Deutsche Bank
OTLK icon

Deutsche Bank’s Outlook Therapeutics OTLK Stock Holding History

Deutsche Bank’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+130,700
New +$81.1K ﹤0.01% 3234
2025
Q3 		– Sell
-2,938
Closed -$4.7K – 3694
2025
Q2 		$4.7K Buy
2,938
+813
+38% +$1.3K ﹤0.01% 3530
2025
Q1 		$2.59K Buy
2,125
+1,419
+201% +$2.49K ﹤0.01% 3544
2024
Q4 		$1.33K Sell
706
-6,626
-90% -$27.3K ﹤0.01% 3571
2024
Q3 		$39.2K Hold
7,332
– – ﹤0.01% 3399
2024
Q2 		$54.1K Buy
7,332
+6,819
+1,329% +$54.7K ﹤0.01% 3311
2024
Q1 		$6.13K Sell
513
-1
-0.2% -$8 ﹤0.01% 3554
2023
Q4 		$4.01K Hold
514
– – ﹤0.01% 3577
2023
Q3 		$2.26K Sell
514
-2,662
-84% -$58.9K ﹤0.01% 3637
2023
Q2 		$111K Sell
3,176
-1,787
-36% -$48.7K ﹤0.01% 3226
2023
Q1 		$108K Buy
4,963
+2,405
+94% +$53.8K ﹤0.01% 3294
2022
Q4 		$55.3K Buy
2,558
+40
+2% +$870 ﹤0.01% 3536
2022
Q3 		$61K Sell
2,518
-396
-14% -$9.21K ﹤0.01% 3534
2022
Q2 		$60K Buy
2,914
+329
+13% +$9.46K ﹤0.01% 3707
2022
Q1 		$92K Sell
2,585
-505
-16% -$15.8K ﹤0.01% 3612
2021
Q4 		$84K Buy
3,090
+529
+21% +$18.9K ﹤0.01% 3776
2021
Q3 		$111K Sell
2,561
-39
-2% -$1.88K ﹤0.01% 3857
2021
Q2 		$129K Buy
+2,600
New +$121K ﹤0.01% 4031
2020
Q1 		– Sell
-1,285
Closed -$15K – 4680
2019
Q4 		$15K Buy
+1,285
New +$29.9K ﹤0.01% 4386
2019
Q3 		– Sell
-20
Closed – – 5163
2019
Q2 		$0 Sell
20
-538
-96% -$25.1K ﹤0.01% 5452
2019
Q1 		$82K Buy
+558
New +$78.8K ﹤0.01% 4372

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Deutsche Bank's OTLK Position: Q2 2026 in Review

Deutsche Bank opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 130,700 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #3234 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in OTLK as recently as Q2 2025.

Deutsche Bank first reported a position in OTLK in Q1 2019 and has held it in 21 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Deutsche Bank held 130,700 shares of Outlook Therapeutics worth $208K as of Q2 2026.
  • Outlook Therapeutics was a new Deutsche Bank position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3234 holding.
  • Deutsche Bank first reported a position in Outlook Therapeutics in Q1 2019 and has held it in 21 quarters since.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.